HeartLight System
Device
CardioFocus, Inc.
Total Payments
$3.0M
Transactions
751
Doctors
163
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.4M | 225 | 46 |
| 2023 | $1.5M | 325 | 90 |
| 2022 | $32.18 | 1 | 1 |
| 2021 | $127,887 | 200 | 72 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Long term medical supply or device loan | $2.5M | 16 | 82.4% |
| Unspecified | $206,292 | 59 | 6.8% |
| Consulting Fee | $171,792 | 33 | 5.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $75,249 | 13 | 2.5% |
| Travel and Lodging | $40,351 | 77 | 1.3% |
| Food and Beverage | $37,087 | 552 | 1.2% |
| Honoraria | $1,500 | 1 | 0.0% |
Payments by Type
General
$2.8M
692 transactions
Research
$206,292
59 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| POST APPROVAL STUDY OF THE HEARTLIGHT ENDOSCOPIC ABLATION SYSTEM FOR THE TREATMENT OF ATRIAL FIBRILATION | CardioFocus, Inc. | $107,106 | 0 |
| Post Approval Study of HeartLight Endoscopic Ablation System | CardioFocus, Inc. | $61,230 | 0 |
| POST APPROVAL STUDY OF THE HEARTLIGHT ENDOSCOPIC ABLATION SYSTEM FOR THE TREATMENT OF ATRIAL FIBRILLATION | CardioFocus, Inc. | $34,608 | 0 |
| POST APPROVAL STUDY OF THE HEARTLOGHT ENDOSCOPIC ABLATION SYSTEM FOR THE TREATMENT OF ATIRAL FIBRILATION | CardioFocus, Inc. | $3,347 | 0 |
Top Doctors Receiving Payments for HeartLight System — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Internal Medicine | Chicago, IL | $155.79 | 1 |
| , M.D | Cardiovascular Disease | Simi Valley, CA | $153.80 | 3 |
| , MD | Specialist | Austin, TX | $153.71 | 1 |
| , M.D | Clinical Cardiac Electrophysiology | Delray Beach, FL | $150.53 | 3 |
| , M.D | Cardiovascular Disease | Ocala, FL | $149.11 | 1 |
| , MD | Cardiovascular Disease | Ocala, FL | $149.11 | 1 |
| , MD | Interventional Cardiology | Saint Cloud, FL | $149.11 | 1 |
| , M.D | Cardiovascular Disease | Ocala, FL | $149.11 | 1 |
| , MD | Vascular Surgery | Ocala, FL | $149.11 | 1 |
| , MD | Cardiovascular Disease | San Diego, CA | $145.34 | 2 |
| , D.O | Interventional Cardiology | Neptune, NJ | $143.88 | 1 |
| , M.D | Clinical Cardiac Electrophysiology | Parlin, NJ | $143.88 | 1 |
| , M.D | Cardiovascular Disease | Tinton Falls, NJ | $143.88 | 1 |
| , MD | Clinical Cardiac Electrophysiology | Milwaukee, WI | $139.53 | 1 |
| Steven Carlson | Internal Medicine | Chula Vista, CA | $138.78 | 3 |
| , MD | Clinical Cardiac Electrophysiology | New Orleans, LA | $127.14 | 2 |
| , MD | Clinical Cardiac Electrophysiology | Ooltewah, TN | $126.91 | 4 |
| , MD | Internal Medicine | Ventura, CA | $126.85 | 1 |
| , MD | Cardiovascular Disease | Saint Helena, CA | $126.00 | 1 |
| , MD | Internal Medicine | Los Angeles, CA | $122.00 | 1 |
| , MD | Cardiovascular Disease | Greenville, SC | $120.81 | 1 |
| , M.D | Cardiovascular Disease | Little Rock, AR | $116.93 | 1 |
| David Haines | — | Royal Oak, MI | $114.73 | 1 |
| , MD | Cardiovascular Disease | Chicago, IL | $114.26 | 1 |
| , MD | Cardiovascular Disease | Chicago, IL | $114.26 | 1 |
Ad
Manufacturing Companies
- CardioFocus, Inc. $3.0M
Product Information
- Type Device
- Total Payments $3.0M
- Total Doctors 163
- Transactions 751
About HeartLight System
HeartLight System is a device associated with $3.0M in payments to 163 healthcare providers, recorded across 751 transactions in the CMS Open Payments database. The primary manufacturer is CardioFocus, Inc..
Payment data is available from 2021 to 2024. In 2024, $1.4M was paid across 225 transactions to 46 doctors.
The most common payment nature for HeartLight System is "Long term medical supply or device loan" ($2.5M, 82.4% of total).
HeartLight System is associated with 4 research studies, including "POST APPROVAL STUDY OF THE HEARTLIGHT ENDOSCOPIC ABLATION SYSTEM FOR THE TREATMENT OF ATRIAL FIBRILATION" ($107,106).